Rakesh Sachdev
Analyst · Morgan Stanley
Thank you, Carey, and good morning, everyone, and welcome. In the third quarter, we are pleased to have reported low single-digit year-over-year growth in both sales and adjusted EBITDA, despite experiencing a modest FX headwind and softness in some end markets, particularly in Asia. This performance demonstrates the resilience of our business model and the importance of our company's diversification and highly variable cost structure. We are reaffirming our full year adjusted EBITDA guidance for the company, excluding Arysta LifeScience, in the range of $425 million to $445 million. Considering increased FX headwinds and existing market conditions, we do expect to come in at the lower end of that range. And this 2018 guidance includes about $5 million of the targeted $25 million in savings, which we expect to realize from the reorganization of Platform into Element Solutions. We're making good progress on this work stream and are pleased to have begun to realize these efficiencies.
Please note that with limited exception in our discussion today, we will focus on continuing operations. This excludes any contribution from our Agricultural Solutions business, Arysta, which we agreed to sell to UPL in a transaction set to close in the coming months. We will update you further today on our progress regarding this transaction. But in summary, we are working towards a timely completion. As you can see on Slide 3, we reported third quarter 2018 net sales of $489 million and adjusted EBITDA of $108 million. Net sales grew 3% on an organic basis while adjusted EBITDA also grew 3% on a constant currency basis. Actual dollar results were impacted by modest currency headwinds, particularly from the Brazilian real and Chinese yuan. We saw organic growth across all our businesses. Positive end market dynamics help drive results in our industrial, graphics and offshore businesses, tempered by softness in Asian electronics. Our industrial business experienced gains across the Americas and Europe while Asia was impacted particularly by automotive markets that remain tepid into Q4. However, we would note Asia makes up 1/4 of that business.
In addition, from a margin perspective, Europe was impacted by growth in Fernox, which is our water treatment business that has a lower-than-average margin.
In electronics assembly and circuit board chemistry, continued weak demand for high-end mobile phones drove lighter volumes in Asia. In the Americas, our circuit board chemistry business realized volume gains through market growth, while Europe was essentially flat. These 2 regions are small relative to our business in Asia. Our semiconductor business saw healthy growth in Q3 as we won some new qualifications. In electronics assembly, organic growth from both volume and mix in Americas and Europe was impacted by Asia softness and FX headwinds. As we look to the fourth quarter, we anticipate some continued demand softness in Asia, but we believe our memory disk and semiconductor businesses, while relatively small, will remain growth drivers. Given our geographic and end-diversity with the electronic supply chain, on the whole, we expect our results to be less impacted by end market demand trends. Our offshore business, again, saw strong organic growth as the general recovery in energy has led to new rigs coming online. We expect continued growth into Q4 but are closely watching the recent energy price declines and their impact on decision making. Our Graphics business saw organic growth in line with our longer-term expectations as we lapped a slower third quarter in 2017 and saw a soft pickup in both Latin America and Asia. Both regions represent a secular tailwind for this business, so the contributions are encouraging.
On EPS, we reported a GAAP diluted loss per share of $0.02 this quarter, which compares to a loss of $0.13 in the third quarter of 2017. This improvement is primarily attributable to a reported income tax benefit, lower interest expense, lower foreign exchange losses and higher operating profit. Our adjusted earnings per share this quarter was $0.04. We would note that adjusting our balance sheet to reflect the anticipated proceeds from the sale of Arysta, and therefore, reducing interest expense through debt paydown, were positively impacted adjusted EPS by about $0.13, which means that the adjusted EPS this quarter would have been about $0.17. We think about that $0.17 as the right earnings per share metric for this business this quarter.
Our adjusted EBITDA increased 1% in reported dollars and increased 3% on a constant currency basis in the quarter over last year. Business mix in the quarter, primarily the outsized contribution of our lower margin industrial business relative to our electronics businesses, muted some of the growth in adjusted EBITDA, which we generally expect to exceed top line growth.
Mix within our electronics businesses was also a factor as the Asian end market represents one of our highest margin areas. Overall, despite softness in certain of our key end markets and moderate FX headwinds, our financial performance this quarter was consistent with our expectations. I would note that we are clearly seeing the same FX and end market dynamics as other specialty companies. However, we believe our diversity in terms of end markets and geographies, insulates us from some of the dramatic swings in earnings associated with changes in end market demand that we see in other chemical companies. We have a resilient business model, and this quarter demonstrates it.
Now let me turn the call over to John, our CFO, who will discuss cash flow and the balance sheet. John?